EVOQ Remedies Ltd approved increasing its authorised share capital to ₹42 crore. They will issue new shares via preferential issues to acquire significant stakes in Poshan Nutriwell (71.95%) and Spazio Formulations (50.36%). The board also approved expanding EVOQ's business to include agricultural produce and agro-processing, subject to shareholder approval. Disclosures have been made to SEBI.